Delivery Order SPE2DB22D2007-SPE2DB24FJ4QJ

Award Date 7/29/24
Potential Completion Date 7/30/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,493.64, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product. The contract has an ultimate completion date of October 22, 2024 and is a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside requirement, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The $6,114.40 fixed-price delivery order has an ultimate completion date of October 31, 2024. Amerisourcebergen, a major pharmaceutical distributor, does not have a set-aside designation for this contract. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of EUFLEXXA 20 MG/2 ML SYRINGE 2ML. The contract is a delivery order with a firm fixed price of $13,380.94 and a period of performance through June 4, 2024. The contract was not set aside for any small business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,987.28 contract is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used in the treatment of various medical conditions. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,130.60, is for the delivery of EUFLEXXA 1% 20 MG/2 ML syringes to support military healthcare programs. The contract has a completion date of October 17, 2024 and utilizes a firm fixed-price delivery order pricing type. This award is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML medical products to the Defense Logistics Agency (DLA). The $8,617.67 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, by the DLA Troop Support Medical. The contract does not have a set-aside designation and is a delivery order placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The $8,751.65 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency. This contract does not have a set-aside designation. The contract has an ultimate completion date of August 14, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The $8,094.04 Firm Fixed Price Delivery Order is for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a prescription medication, with a period of performance through May 10, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,688.93 firm-fixed-price delivery order is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a completion date of November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,300.52 delivery order is for the supply of EUFLEXXA 1% 20 MG/2 ML syringes. The contract has an ultimate completion date of October 24, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ4QJ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract, valued at $2,004.98, is a Firm Fixed Price Delivery Order with a completion date of July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by various agencies, including the Department of Justice Federal Bureau of Investigation and the DLA Troop Support Medical, to supply a range of critical medical commodities and prescription drugs to support government healthcare programs and military treatment facilities. This award does not have a set-aside designation.

Generated 10/28/24, 9:58 AM